XML 20 R8.htm IDEA: XBRL DOCUMENT v3.5.0.2
Consolidated Statements Of Cash Flows - USD ($)
$ in Thousands
6 Months Ended
Jun. 30, 2016
Jun. 30, 2015
Operating Activities    
Net income $ 24,244 $ 29,975
Adjustments to reconcile net income to net cash provided by operating activities:    
Accretion and amortization 146 (2,976)
Provision for loan losses 1,661 3,724
Depreciation 3,134 3,027
Deferred income tax expense 2,548 4,549
Net periodic employee benefit cost 257 413
Realized investment securities gains (1,256) (2,130)
Impairment losses on investment securities 411 0
Stock-compensation expense 1,200 1,060
Increase in value of bank-owned life insurance (1,527) (1,547)
Loans originated for sale (5,913) (9,191)
Proceeds from the sale of loans originated for sale 5,801 9,327
Gain on sale of loans (139) (167)
Gain on sale of insurance division 0 (11,084)
Change in accrued interest receivable (996) (1,012)
Change in other assets (18,105) 5,703
Change in other liabilities 26,282 (19,307)
Net Cash Provided by Operating Activities 37,748 10,364
Investing Activities    
Proceeds from sales of securities available-for-sale 1,256 290
Proceeds from maturities and calls of securities available-for-sale 34,009 33,323
Proceeds from maturities and calls of securities held-to-maturity 5,549 7,648
Purchases of securities available-for-sale (63,458) (67,911)
Net increase in loans (40,883) (31,705)
Purchases of premises and equipment (1,391) (978)
Disposals of premises and equipment 376 0
Proceeds from sale of insurance division 0 15,250
Net Cash Used in Investing Activities (64,542) (44,083)
Financing Activities    
Net increase in non-interest-bearing deposits 30,794 18,250
Net increase in interest-bearing deposits 27,806 11,985
Net increase (decrease) in short-term borrowings (1,195) 18,240
Purchases of treasury stock (10,018) 0
Proceeds from exercise of stock options, net of tax benefit 682 996
Proceeds from exercise of warrants 0 1,896
Dividends paid (12,812) (12,452)
Net Cash Provided by Financing Activities 35,257 38,915
Increase in Cash and Cash Equivalents 8,463 5,196
Cash and cash equivalents at beginning of period 70,113 148,228
Cash and Cash Equivalents at End of Period $ 78,576 $ 153,424